Roy E Shore

Author PubWeight™ 72.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cancer consequences of the Chernobyl accident: 20 years on. J Radiol Prot 2006 3.03
2 Solid cancer incidence in atomic bomb survivors exposed in utero or as young children. J Natl Cancer Inst 2008 2.61
3 Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003. BMJ 2010 2.50
4 Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiol Biomarkers Prev 2002 2.42
5 Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study. Breast Cancer Res 2004 2.03
6 Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study. J Natl Cancer Inst 2010 1.91
7 The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950-2001. Radiat Res 2013 1.79
8 Radiation-related heart disease: current knowledge and future prospects. Int J Radiat Oncol Biol Phys 2010 1.72
9 Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays. Cancer Epidemiol Biomarkers Prev 2005 1.67
10 Reproducibility of serum cytokines and growth factors. Cytokine 2008 1.61
11 Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys 2008 1.58
12 Radiation dose and cataract surgery incidence in atomic bomb survivors, 1986-2005. Radiology 2012 1.57
13 Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int J Cancer 2004 1.52
14 Circulating inflammation markers and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2011 1.44
15 Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer. Int J Cancer 2004 1.33
16 Postmenopausal levels of endogenous sex hormones and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2009 1.24
17 Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study. J Natl Cancer Inst 2007 1.18
18 Reliability of tumor markers, chemokines, and metastasis-related molecules in serum. Eur Cytokine Netw 2009 1.16
19 Long-term radiation-related health effects in a unique human population: lessons learned from the atomic bomb survivors of Hiroshima and Nagasaki. Disaster Med Public Health Prep 2011 1.15
20 Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study. Cancer Causes Control 2010 1.14
21 Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer. Cancer Lett 2008 1.09
22 Comments on Estimating Risks of Low Radiation Doses-A Critical Review of the BEIR VII Report and Its Use of the Linear No-Threshold (LNT) Hypothesis by Edward J. Calabrese and Michael K. O'Connor. Radiat Res 2015 1.07
23 Postmenopausal levels of sex hormones and risk of breast carcinoma in situ: results of a prospective study. Int J Cancer 2005 1.03
24 Circulating estrogen metabolites and risk for breast cancer in premenopausal women. Cancer Epidemiol Biomarkers Prev 2009 1.02
25 Thyroid cancer risk 40+ years after irradiation for an enlarged thymus: an update of the Hempelmann cohort. Radiat Res 2010 1.01
26 Pesticide product use and risk of non-Hodgkin lymphoma in women. Environ Health Perspect 2004 1.00
27 Postoperative cataract cases among atomic bomb survivors: radiation dose response and threshold. Radiat Res 2007 0.99
28 Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study. Hum Mutat 2011 0.98
29 DNA methylation in pre-diagnostic serum samples of breast cancer cases: results of a nested case-control study. Cancer Epidemiol 2010 0.98
30 Uncertainties in estimating health risks associated with exposure to ionising radiation. J Radiol Prot 2013 0.98
31 Reproducibility of serum pituitary hormones in women. Cancer Epidemiol Biomarkers Prev 2008 0.95
32 Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study. Breast Cancer Res 2013 0.95
33 Insulin-like growth factor II and colorectal cancer risk in women. Cancer Epidemiol Biomarkers Prev 2002 0.95
34 Polymorphisms in RAD51, XRCC2, and XRCC3 are not related to breast cancer risk. Cancer Epidemiol Biomarkers Prev 2008 0.95
35 Body mass index and risk of second primary breast cancer: the WECARE Study. Breast Cancer Res Treat 2011 0.93
36 Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer. Cancer Epidemiol 2012 0.92
37 Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report. Eur J Cancer 2013 0.90
38 Factors associated with inflammation markers, a cross-sectional analysis. Cytokine 2011 0.89
39 Reliability of serum assays of iron status in postmenopausal women. Ann Epidemiol 2006 0.89
40 Endogenous hormones and coronary heart disease in postmenopausal women. Atherosclerosis 2011 0.89
41 Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. 1995. Radiat Res 2012 0.89
42 Statistical methods for analysis of radiation effects with tumor and dose location-specific information with application to the WECARE study of asynchronous contralateral breast cancer. Biometrics 2008 0.89
43 Premenopausal serum androgens and breast cancer risk: a nested case-control study. Breast Cancer Res 2012 0.89
44 Cox regression model with time-varying coefficients in nested case-control studies. Biostatistics 2010 0.88
45 IGF-I, IGFBP-3 and breast cancer in young women: a pooled re-analysis of three prospective studies. Eur J Cancer Prev 2005 0.87
46 Use of anti-inflammatory and non-narcotic analgesic drugs and risk of non-Hodgkin's lymphoma (NHL) (United States). Cancer Causes Control 2002 0.87
47 Circulating vitamin d and risk of epithelial ovarian cancer. J Oncol 2009 0.87
48 Genetic variants in hormone-related genes and risk of breast cancer. PLoS One 2013 0.85
49 History of antibiotic use and risk of non-Hodgkin's lymphoma (NHL). Int J Cancer 2003 0.84
50 Personal and occupational exposure to organic solvents and risk of non-Hodgkin's lymphoma (NHL) in women (United States). Cancer Causes Control 2005 0.84
51 Long-term effects of the rain exposure shortly after the atomic bombings in Hiroshima and Nagasaki. Radiat Res 2014 0.83
52 Cardiovascular disease risk among atomic bomb survivors exposed in utero, 1978-2003. Radiat Res 2008 0.82
53 Reproductive status at first diagnosis influences risk of radiation-induced second primary contralateral breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys 2012 0.81
54 Circulating prolactin levels and risk of epithelial ovarian cancer. Cancer Causes Control 2013 0.81
55 Re: C-reactive protein and risk of breast cancer. J Natl Cancer Inst 2008 0.80
56 Circulating enterolactone and risk of endometrial cancer. Int J Cancer 2006 0.80
57 Development and validation of a food frequency questionnaire for Korean Americans. Int J Food Sci Nutr 2002 0.78
58 Breast cancer risk 55+ years after irradiation for an enlarged thymus and its implications for early childhood medical irradiation today. Cancer Epidemiol Biomarkers Prev 2010 0.78
59 Ninth Annual Warren K. Sinclair Keynote Address: effects of childhood radiation exposure: an issue from computed tomography scans to Fukushima. Health Phys 2013 0.77
60 Radiation exposure and the risk of mortality from noncancer respiratory diseases in the life span study, 1950-2005. Radiat Res 2013 0.76
61 Estimation of health risks associated with occupational radiation exposure: addressing measurement error and minimum detectable exposure level. Health Phys 2006 0.76
62 Cox regression analysis in presence of collinearity: an application to assessment of health risks associated with occupational radiation exposure. Lifetime Data Anal 2007 0.76
63 Radiation unlikely to be responsible for high cancer rates among distal Hiroshima A-bomb survivors. Environ Health Prev Med 2009 0.76
64 Radiation effects on cancer risks in the Life Span Study cohort. Radiat Prot Dosimetry 2012 0.76
65 Funding crisis at the Radiation Effects Research Foundation. J Radiol Prot 2004 0.75
66 Implications of radiation epidemiologic data for risk assessment and radiation protection. Health Phys 2011 0.75
67 Estimating the dose response relationship for occupational radiation exposure measured with minimum detection level. Health Phys 2004 0.75
68 Potential funding crisis for the Radiation Effects Research Foundation. Lancet 2004 0.75
69 A method for estimating occupational radiation doses subject to minimum detection levels. Health Phys 2003 0.75